SCHEMBL3987484

SCHEMBL3987484

O=C(CC(=O)c1ccc(O)cc1)c1ccc(O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.65
RAB9A P51151 2/20 0.65
PTPN1 P18031 1/20 0.65
KDM4E B2RXH2 2/20 0.62
TDP1 Q9NUW8 2/20 0.62
BLM P54132 2/20 0.62
ALDH1A1 P00352 1/20 0.62
ABL1 P00519 1/20 0.62
POLB P06746 1/20 0.62
ALPI P09923 1/20 0.62
GAA P10253 1/20 0.62
ALPG P10696 1/20 0.62
APEX1 P27695 1/20 0.62
CASP3 P42574 1/20 0.62
RECQL P46063 1/20 0.62
CASP7 P55210 1/20 0.62
CASP6 P55212 1/20 0.62
MCL1 Q07820 1/20 0.62
RIN1 Q13671 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL127249 0.91 MEN1 (0.77) NPC1RAB9APTPN1KDM4ETDP1
SCHEMBL21414950 0.89 RAB9A (0.69) NPC1RAB9APTPN1KDM4ETDP1
SCHEMBL16127292 0.89 RAB9A (0.70) NPC1RAB9APTPN1KDM4ETDP1
SCHEMBL2715371 0.87 PTPN1 (0.58) NPC1RAB9APTPN1KDM4ETDP1
SCHEMBL6351346 0.85 HSD17B3 (0.57) NPC1RAB9APTPN1KDM4ETDP1
SCHEMBL18757667 0.85 NPC1 (0.56) NPC1RAB9APTPN1KDM4ETDP1
SCHEMBL27745056 0.85 BLM (0.61) NPC1RAB9APTPN1KDM4ETDP1
SCHEMBL13540737 0.85 HSD17B3 (0.52) NPC1RAB9APTPN1KDM4ETDP1
SCHEMBL29131412 0.84 ERCC5 (0.69) NPC1RAB9APTPN1KDM4ETDP1
SCHEMBL27800112 0.84 BLM (0.57) NPC1RAB9APTPN1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4122721-A None JP disclosed
US-10023752-B2 Conductive material and substrate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-07-17 US disclosed
US-10023752-B2 Conductive material and substrate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-07-17 US disclosed
US-20170174922-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-06-22 US disclosed
US-20170174922-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-06-22 US disclosed
US-20170130070-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-11 US disclosed
US-20170130071-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-11 US disclosed
US-20170130071-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-11 US disclosed
US-20170130070-A1 CONDUCTIVE MATERIAL AND SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-11 US disclosed
US-9360753-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-07 US disclosed
US-20130029270-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-01-31 US disclosed
US-20120208125-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-08-16 US disclosed
US-20120208125-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-08-16 US disclosed
EP-1893623-B1 C-GLYCOSIDE COMPOUNDS AND USE THEREOF FOR DEPIGMENTING THE SKIN OREAL (FR) 2009-05-20 EP disclosed
US-20080193400-A1 C-Glycoside Compounds and Use Thereof for Depigmenting the Skin L'OREAL (FR) 2008-08-14 US disclosed
US-20080193400-A1 C-Glycoside Compounds and Use Thereof for Depigmenting the Skin L'OREAL (FR) 2008-08-14 US disclosed
US-20080193400-A1 C-Glycoside Compounds and Use Thereof for Depigmenting the Skin L'OREAL (FR) 2008-08-14 US disclosed
EP-0781146-A1 SUPER ABSORBENT POLYMER COMPOSITION Kao Corporation (JP) 1997-07-02 EP disclosed
WO-1996007437-A1 SUPER ABSORBENT POLYMER COMPOSITION KAO CORPORATION (JP) 1996-03-14 WO disclosed
JP-H04122721-A MAIN CHAIN-TYPE THERMOTROPIC LIQUID CRYSTAL POLYMERIC MATERIAL SHIRAI HIROYOSHI 1992-04-23 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193400-A1 C-Glycoside Compounds and Use Thereof for Depigmenting the Skin RER1, CBR3, NR1H3 NPC1 995/4885RAB9A 2725/4885PTPN1 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.